Ignacio Gainza-Tejedor et al. 2023. Adherence, acceptability and tolerability of venlafaxine extended release at dose of 300 mg/day in patients with major depressive disorder. Actas Españolas de Psiquiatría. 51, 5 (Sep. 2023), 193–201.